Ozempic is the name brand for the generic drug "semaglutide." Ozempic is approved for Type 2 Diabetes, while its sister drug Wegovy is approved for Obesity, for the prevention of recurrent cardiovascular disease, and for people with kidney disease
Rogers, MD, FACS, the immediate past president of the American Society for Metabolic and Bariatric Surgery (ASMBS) and a professor emerita of bariatric surgery at Penn State Health in Hershey, Pennsylvania, explained the most frequent scenario in which surgeons encounter patients taking GLP-1RA drugs
10.1378/chest.117.3.914 38
A single 30 mg vial, for instance, is a supply that covers many weekly doses it is not a 30 mg injection
References: 1 Xie, Y., Choi, T., & Al-Aly, Z